GlassScriptPhysician profile
Jennifer Wilkinson
NPI 1710647870
$6,109.62
in general payments reported to CMS, 2019-2025
49 companies · $2,107 in 2025
The $2,107 reported for 2025 was more than what 93% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,199 · 2023: $1,046 · 2024: $1,758 · 2025: $2,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,866 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,865.56 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $899.76 | 2022-2025 | Farxiga, Airsupra, Bevespi Aerosphere |
| Abbvie INC. | $826.97 | 2022-2025 | |
| Pfizer INC. | $432.02 | 2022-2025 | |
| Novo Nordisk INC | $395.78 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Axsome Therapeutics, INC. | $259.57 | 2023-2025 | Auvelity, Sunosi |
| Lilly USA, LLC | $253.95 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $220.10 | 2022-2025 | Trelegy Ellipta, Rotarix, Pediarix |
| Novartis Pharmaceuticals Corporation | $215.78 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.93 | 2022-2025 | Jardiance, Jascayd |
| Amgen INC. | $208.73 | 2022-2025 | Otezla, Repatha, Evenity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $189.05 | 2025 | Caplyta |
| Corcept Therapeutics | $186.35 | 2023-2024 | Korlym |
| Idorsia Pharmaceuticals US INC | $157.28 | 2023-2025 | Quviviq, Quviviq |
| Otsuka America Pharmaceutical, INC. | $144.88 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Harmony Biosciences LLC | $111.24 | 2022-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $110.35 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Alkermes, INC. | $103.52 | 2022-2025 | Vivitrol, Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $93.35 | 2023-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $74.34 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.87 | 2022-2023 | Trulance, Xifaxan |
| Exact Sciences Corporation | $69.73 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $66.10 | 2023-2025 | Keveyis, Recorlev |
| Vanda Pharmaceuticals INC. | $57.43 | 2024-2025 | Fanapt |
| Phathom Pharmaceuticals, INC. | $53.00 | 2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $52.18 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $50.86 | 2023-2024 | Opsumit, Uptravi |
| Almatica Pharma LLC | $48.23 | 2022-2024 | Loreev Xr |
| Aimmune Therapeutics, INC. | $42.58 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $38.84 | 2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $35.47 | 2023 | Xarelto |
| Lundbeck LLC | $35.40 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $34.34 | 2022-2025 | Vaxelis, Gardasil 9, Rotateq |
| E.R. Squibb & Sons, L.L.C. | $34.29 | 2024 | Eliquis |
| Kowa Pharmaceuticals America, INC. | $33.93 | 2025 | Zoryve |
| W. L. Gore & Associates, INC. | $25.90 | 2025 | Gore Cardioform Septal Occluder |
| Organon LLC | $25.51 | 2022 | |
| Insulet Corporation | $23.32 | 2024 | Omnipod |
| Biohaven Pharmaceutical Holding Company LTD. | $21.90 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.05 | 2023 | |
| Supernus Pharmaceuticals, INC. | $19.53 | 2025 | Qelbree |
| Biogen, INC. | $19.20 | 2025 | Zurzuvae |
| Azurity Pharmaceuticals, INC. | $18.39 | 2024 | Edarbi |
| Collegium Pharmaceutical, INC. | $18.22 | 2025 | Jornay Pm |
| Amarin Pharma, INC. | $17.74 | 2022 | |
| Eisai INC. | $17.43 | 2024 | |
| Recordati_rare_diseases_inc. | $16.75 | 2025 | Isturisa |
| Teva Pharmaceuticals USA, INC. | $16.51 | 2024 | Austedo Xr |
| Neurocrine Biosciences, INC. | $15.75 | 2025 | |
| Hologic Sales and Service, LLC | $15.22 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.